Sinusitis affects millions of people every year and is a common reason for missed days from work or school. At Andros ENT & Sleep Center in Inver Grove Heights and Roseville, Minnesota, Inell Rosario, MD, specializes in diagnosing and treating sinusitis. Dr. Rosario offers both nonsurgical and surgical treatment options to clear up your sinusitis and improve your breathing. Call the office nearest you or book an appointment online today.
Sinusitis is an infection in the sinus cavity. The sinus cavity is the air-filled space in your skull. When you breathe in through your nose, the sinus cavity removes germs and dirt, and moistens the air before sending it to your lungs.
With sinusitis, swelling and inflammation of the mucosal tissue that lines that sinus cavity obstruct this process, making it harder to breathe through your nose. Sinusitis also affects fluid drainage, which may lead to congestion, a runny nose, or post-nasal drip.
Sinusitis may be acute, lasting a few days or a few weeks. However, you might have chronic sinusitis if your sinusitis symptoms last three months or more.
Sinusitis symptoms vary in type and severity but most often follow a cold or flu infection. Symptoms include:
Bacteria and viruses are the most common causes of sinusitis; however, you may develop this sinus problem if you have seasonal allergies such as hay fever.
When you visit Andros ENT & Sleep Center, Dr. Rosario conducts a comprehensive history and physical to fully understand your condition so she can develop the most effective treatment plan.
During your evaluation, she reviews your symptoms and medical history and examines your nasal and sinus cavity. She diagnoses sinusitis after your physical exam.
To confirm a diagnosis and assess the severity of your infection, she may send samples of your nasal discharge to the lab for an evaluation. Dr. Rosario may also request imaging tests, such as a CT scan or MRI, of your sinus cavity.
Dr. Rosario develops individualized treatment plans for sinusitis based on the severity and frequency of your symptoms and the underlying cause. Initially, she may recommend medication to treat your infection and reduce inflammation and swelling, such as:
When conservative interventions fail to improve your chronic sinusitis, Dr. Rosario may recommend a balloon sinuplasty.
During this minimally invasive procedure, Dr. Rosario uses a catheter to insert a special balloon through your nose and into your sinus cavity. She then inflates the balloon, compressing the inflamed and swollen tissue and widening the area to improve breathing.
For expert care of your sinusitis, call Andros ENT & Sleep Center or schedule an appointment using the online booking button today.
SINUVA is a non-surgical treatment that shrinks nasal polyps and may be an alternative to surgery. SINUVA is for adults 18 years of age or older with nasal polyps who have had ethmoid sinus surgery.
SINUVA may be appealing to nasal polyp sufferers who would prefer an in-office treatment instead of sinus surgery in an operating room. SINUVA is placed during an office visit and patients are usually able to resume normal activities with little to no recovery days needed.
SINUVA was clinically proven to1,2
The most common adverse reactions observed in clinical trials were bronchitis, upper respiratory or middle ear infection, headache, light-headedness, asthma and nose bleed.
SINUVA is not for people with hypersensitivity to corticosteroids or those with nasal ulcers or trauma. See more Important Safety Information below.
If you have a known hypersensitivity to the mometasone furoate drug or any of the ingredients in SINUVA, do not use SINUVA. Hypersensitivity reactions, including rash, itch, and swelling have been reported with use of steroids. If steroid effects such as Cushing Syndrome and adrenal suppression appear, consult your healthcare professional.
SINUVA is made from bioabsorbable polymers designed to soften over time. As the implant softens and polyps decrease, the implant may be expelled out of the nose on its own or with actions such as sneezing or forceful nose blowing. The implant can be removed 90 days after placement or earlier at the physician’s discretion. Repeat administration of SINUVA has not been studied.
As with other endoscopic sinus procedures, there are risks associated with the insertion or removal of SINUVA. SINUVA should be inserted by physicians trained in otolaryngology. Discuss risks related to insertion or removal of SINUVA with your healthcare professional.
Your healthcare professional will monitor the nasal tissue adjacent to the SINUVA Sinus Implant for any signs of bleeding, irritation, infection, or perforation. SINUVA should not be used in patients with nasal ulcers or trauma.
The most common adverse reactions observed (in more than 1% of subjects and that occurred more frequently in the treatment group compared to control) in clinical studies were bronchitis, upper respiratory or middle ear infection, headache, lightheadedness, asthma, and nose bleed.
If you experience excessive nasal bleeding, worsening symptoms of infections, viral eye infections, or symptoms suggesting that the implant has moved, such as irritation or a choking sensation in the back of the throat, immediately contact a healthcare professional.
Close monitoring is recommended if you have a change of vision or a history of increased intraocular pressure, glaucoma and/or cataracts.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch (www.fda.gov/medwatch) or call 1-800-FDA-1088. You may also report side effects to Intersect ENT at 1-866-531-6004.
SINUVA® Sinus Implant is a steroid-releasing (mometasone furoate) implant indicated for the treatment of nasal polyps, in patients ≥ 18 years of age who have had ethmoid sinus surgery.
RX Only. For additional important risk and use information about SINUVA, please see Full Prescribing Information.
1 SINUVA Prescribing Information, Intersect ENT. December 2017
2 Kern RC, Stolovitzky JP, Silvers SL, et al. A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps. Int Forum Allergy Rhinol.2018;8:471–81.